ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for families: drug trial targets inherited Alzheimer's
Disease control OngoingThis study tests whether experimental drugs can slow down memory and thinking problems in people who have a genetic mutation that causes Alzheimer's disease. About 490 adults aged 18-80 with a family history of early-onset Alzheimer's will receive either the study drug or a place…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New Alzheimer's drug aims to clear brain plaques
Disease control OngoingThis study tests an experimental drug called RO7126209 in 241 people with early to moderate Alzheimer's disease. The goal is to see if the drug is safe and how it affects amyloid plaques in the brain. Participants receive multiple doses of the drug or a placebo through an IV.
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Gum treatment may slow Alzheimer's: new trial launches
Disease control ENROLLING_BY_INVITATIONThis study looks at whether treating severe gum disease can help slow down Alzheimer's disease. The idea is that gum disease causes body-wide inflammation, which might make Alzheimer's worse. About 26 people with both conditions will get gum treatment and be tracked for 2 years w…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Hope for families: new combo therapy targets inherited Alzheimer's
Disease control OngoingThis study tests whether adding an experimental drug (E2814) to a standard Alzheimer's treatment (lecanemab) can slow memory loss and brain changes in people who have a genetic mutation that causes Alzheimer's. About 197 adults aged 18-80 with mild symptoms or no symptoms but car…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 05, 2026 11:52 UTC
-
Blood test may speed up Alzheimer's diagnosis in veterans
Diagnosis TerminatedThis study aimed to see if using a blood test (PrecivityAD2) early in memory clinics could help doctors diagnose Alzheimer's disease or other dementias more quickly. Participants with memory problems would have been randomly assigned to get the blood test results right away or af…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: C2N Diagnostics • Aim: Diagnosis
Last updated May 17, 2026 04:32 UTC